Jefferies Downgrades Ironwood Pharmaceuticals to Hold, Lowers Price Target to $0.7

Benzinga · 04/15 11:50
Jefferies analyst Amy Li downgrades Ironwood Pharmaceuticals (NASDAQ:IRWD) from Buy to Hold and lowers the price target from $8 to $0.7.